V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006428 | 290004794 | 1.57 | 55.6 | Palliative (P) | 2016-02-08 | 2016-03-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290018683 | CARBOPLATIN + CETUXIMAB + FU |
| 290006429 | 290004795 | 1.53 | 0 | Palliative (P) | null | 2016-05-13 | CompARE Trial | N | N | 290018684 | SUNITINIB |
| 290006430 | 290004796 | 1.66 | 68 | Palliative (P) | 2016-01-14 | 2016-01-14 | Trial Unspecified | 02 | Y | 290018686 | PACLITAXEL |
| 290006431 | 290007036 | 1.63 | null | Curative (C) | null | 2013-12-08 | FLUOROURACIL + MITOMYCIN | Y | Y | 290018689 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006432 | 290004798 | null | null | Palliative (P) | null | 2016-01-07 | CARBOPLATIN + RT | null | N | 290018699 | NIVOLUMAB |
| 290006433 | 290007037 | null | null | Curative (C) | 2014-04-12 | 2014-05-14 | Capecitabine | 02 | N | 290018700 | CAPECITABINE + MITOMYCIN + RT |
| 290006434 | 290004801 | 1.65 | null | Not known (9) | 2014-06-06 | 2014-06-06 | CARBOPLATIN + PACLITAXEL | N | N | 290018703 | LANREOTIDE |
| 290006435 | 290004802 | 1.51 | 68.6 | Palliative (P) | 2018-09-04 | 2018-10-11 | Irinotecan 14day | N | N | 290018707 | CAPECITABINE |
| 290006436 | 290004802 | 1.78 | 81 | Curative (C) | 2015-07-20 | 2015-12-29 | Capecitabine 35days + RT | N | N | 290018707 | CETUXIMAB + RT |
| 290006437 | 290004803 | null | 84.9 | Curative (C) | null | 2018-02-18 | CISPLATIN + RT | null | null | 290018724 | BALLAD TRIAL |
| 290006438 | 290004803 | 1.7 | 59 | Curative (C) | 2016-09-01 | 2016-09-07 | Capecitabine + Cisplatin | 02 | N | 290018724 | COMPARE TRIAL |
| 290006439 | 290004803 | 1.67 | null | null | 2017-04-27 | 2017-07-18 | CETUXIMAB | N | N | 290018724 | CAPECITABINE + CARBOPLATIN |
| 290006440 | 290004803 | 1.7 | 75.5 | Curative (C) | 2014-06-19 | 2014-07-02 | Cetuximab + Radiotherapy Load | 02 | N | 290018724 | CISPLATIN + RT |
| 290006441 | 290004803 | 1.57 | 77 | Palliative (P) | 2017-08-10 | 2017-08-11 | EOX | N | null | 290018724 | CARBOPLATIN + ETOPOSIDE |
| 290006442 | 290004805 | 1.8 | 64.2 | null | 2017-04-10 | 2017-04-10 | Capecitabine (14 days)+Carboplatin | 2 | Y | 290018744 | LANREOTIDE |
| 290006443 | 290004807 | null | 50.9 | null | 2017-04-15 | 2017-04-18 | Cisplatin + Radiotherapy | N | null | 290018745 | DOCETAXEL |
| 290006444 | 290004808 | 1.52 | 72 | Curative (C) | 2018-04-15 | 2018-05-10 | LANREOTIDE | N | N | 290018751 | BCG |
| 290006445 | 290004809 | 1.62 | 65 | Palliative (P) | null | 2017-01-19 | Paclitaxel (2 or 3 weekly) | N | N | 290018751 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006446 | 290004811 | 1.77 | 78.7 | Adjuvant (A) | 2018-01-09 | 2018-01-10 | LANREOTIDE | N | N | 290018757 | CISPLATIN + RT |
| 290006447 | 290004812 | 1.8 | 99.6 | Curative (C) | 2016-12-20 | 2016-12-25 | BORTEZOMIB + THALIDOMIDE | N | N | 290018772 | CAPECITABINE + MITOMYCIN + RT |
| 290006448 | 290004813 | 1.89 | 76.1 | Palliative (P) | 2018-04-02 | 2018-04-28 | CAPECITABINE + IRINOTECAN | 02 | N | 290018779 | CARBOPLATIN + CETUXIMAB + FU |
| 290006449 | 290004813 | 1.62 | null | Palliative (P) | 2012-02-08 | 2013-11-02 | Irinotecan | 2 | Y | 290018779 | CISPLATIN |
| 290006450 | 290004814 | 1.59 | null | Curative (C) | 2015-09-08 | 2015-10-24 | Sunitinib | N | null | 290018789 | CETUXIMAB + RT |
| 290006451 | 290004816 | 1.68 | 80.4 | Not known (9) | null | 2013-09-08 | CETUXIMAB | N | null | 290018796 | LANREOTIDE |
| 290006452 | 290004818 | 1.54 | 77 | Not known (9) | 2013-08-11 | 2013-09-21 | Rituximab | 02 | N | 290018801 | CAPECITABINE + RT |
| 290006453 | 290004819 | 1.58 | 84.3 | Palliative (P) | 2017-02-04 | 2017-02-11 | Capecitabine + Mitomycin | N | N | 290018811 | CAPECITABINE + CISPLATIN |
| 290006454 | 290004820 | 1.62 | 80.8 | null | 2016-07-05 | 2016-07-09 | Capecitabine + Oxaliplatin 21day | N | N | 290018815 | FLUOROURACIL + MITOMYCIN |
| 290006455 | 290004822 | 1.85 | null | Curative (C) | null | 2017-12-14 | Capecitabine | N | N | 290018818 | ETOPOSIDE + IFOSFAMIDE |
| 290006456 | 290004823 | 1.84 | null | Curative (C) | null | 2018-07-15 | Sunitinib | null | null | 290018820 | CETUXIMAB + CISPLATIN + FU |
| 290006457 | 290007045 | null | 74.5 | Curative (C) | 2018-04-20 | 2018-05-08 | Cetuximab 7 day (>Cycle 2) | 2 | N | 290018825 | RITUXIMAB |
| 290006458 | 290007045 | 0 | 80 | Adjuvant (A) | 2015-05-27 | 2015-06-02 | Cisplatin 7 day | 2 | N | 290018825 | CAPECITABINE |
| 290006459 | 290008267 | 1.57 | 87 | Curative (C) | 2015-09-24 | 2015-10-18 | Capecitabine + Oxaliplatin 21day | N | N | 290018852 | TRIAL |
| 290006460 | 290004825 | 1.87 | null | Curative (C) | null | 2017-01-23 | CAPECITABINE + RT | N | N | 290018862 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006461 | 290004826 | 1.63 | 86 | Curative (C) | null | 2017-07-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290018862 | CISPLATIN |
| 290006462 | 290004827 | 1.74 | 77.9 | Curative (C) | null | 2017-03-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | 290018884 | CARBOPLATIN |
| 290006463 | 290004828 | 1.76 | 74.7 | Neo-adjuvant (N) | null | 2013-07-15 | Capecitabine + Cisplatin | N | N | 290018888 | SUNITINIB |
| 290006464 | 290004829 | 1.57 | 72 | Curative (C) | 2015-01-10 | 2015-01-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290018888 | CARBOPLATIN + RT |
| 290006465 | 290004830 | null | 83.1 | null | 2015-12-19 | 2016-02-07 | CARBOPLATIN + FLUOROURACIL | N | N | 290018906 | LANREOTIDE |
| 290006466 | 290007938 | 1.84 | 109 | Curative (C) | 2015-04-08 | 2015-05-23 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 290018938 | CISPLATIN |
| 290006467 | 290004832 | 1.6 | 66 | Curative (C) | null | 2018-07-04 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290018944 | CISPLATIN + RT |
| 290006468 | 290004833 | null | 61 | Palliative (P) | 2017-09-17 | 2017-10-04 | PACLITAXEL | null | null | 290018947 | REGORAFENIB |
| 290006469 | 290004833 | 1.74 | 55 | Palliative (P) | 2015-05-20 | 2016-04-12 | CHOP R - 21 days | N | N | 290018947 | CARBOPLATIN + ETOPOSIDE |
| 290006470 | 290004835 | 1.74 | null | Palliative (P) | 2014-10-24 | 2014-11-19 | Trial Unspecified | 02 | Y | 290018960 | EVEROLIMUS |
| 290006471 | 290004836 | 1.66 | 108 | Adjuvant (A) | 2016-10-16 | 2016-10-17 | Trial Unspecified | 02 | Y | 290018965 | CAPECITABINE + OXALIPLATIN |
| 290006472 | 290007051 | null | 62.3 | Adjuvant (A) | 2013-06-07 | 2013-10-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 290018966 | CAPECITABINE + OXALIPLATIN |
| 290006473 | 290007051 | 1.63 | 53.7 | Palliative (P) | 2016-06-08 | 2016-06-08 | CETUXIMAB + IRINOTECAN + MDG | N | N | 290018966 | ACE |
| 290006474 | 290004837 | 1.47 | 63 | Palliative (P) | 2016-06-10 | 2016-06-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 290018982 | INTERAACT TRIAL |
| 290006475 | 290007940 | 1.47 | 50.8 | Palliative (P) | 2014-07-04 | 2016-09-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290018989 | CAPECITABINE + CISPLATIN |
| 290006476 | 290007940 | null | 56 | Curative (C) | 2018-10-05 | 2018-11-02 | CAPECITABINE + OXALIPLATIN | 02 | Y | 290018989 | MITOMYCIN |
| 290006477 | 290007940 | 1.68 | 49.8 | Curative (C) | 2015-02-24 | 2015-03-25 | Capecitabine + Oxaliplatin 21day | N | Y | 290018989 | CAPECITABINE + MITOMYCIN + RT |